The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
320 jobs Number of planned job losses
Announcement Date
11 July 2003
Employment effect (start)
1 July 2003
Foreseen end date
1 June 2006
Description
Merck Santé, subsidiary of Merck KGaA, announced a restructuring programme for its production and research and development (R&D) units in France. 320 jobs are affected at the Lacassagne (Lyon) unit. Half of the R&D department will be closed by the end of 2004 and half of the production department will be closed by mid-2006. Production will be transfered to the unit of Semoy (Loiret) and in Spain.
The idea of the restructuring plan comes from two studies: 'Ipso' and 'Everest' from Boston Consulting Group and Accenture.
Sources
11 July 2003: Les Echos
Citation
Eurofound (2003), Merck santé, Internal restructuring in France, factsheet number 59300, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/59300.